American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$544M |
| 2 |
Apple
AAPL
|
+$224M |
| 3 |
Exxon Mobil
XOM
|
+$219M |
| 4 |
Meta Platforms (Facebook)
META
|
+$189M |
| 5 |
CRH
CRH
|
+$177M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$402M |
| 2 |
Colgate-Palmolive
CL
|
+$255M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$175M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.58% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Ventyx Biosciences
VTYX
$164M
| $59.8K | ﹤0.01% |
+25,883
| New | +$59.8K |
|
|
LAR
2777
Lithium Argentina AG
LAR
$490M
| $59.5K | ﹤0.01% |
18,680
| – | – |
|
2778
BioAtla
BCAB
$45.5M
| $59.4K | ﹤0.01% |
43,391
+11,503
| +36% | +$15.8K |
|
2779
Frontier Group Holdings
ULCC
$1.18B
| $57.7K | ﹤0.01% |
11,713
-68,435
| -85% | -$337K |
|
2780
Arbutus Biopharma
ABUS
$855M
| $57.1K | ﹤0.01% |
18,486
-107,728
| -85% | -$333K |
|
|
GAU
2781
Galiano Gold
GAU
$654M
| $54.5K | ﹤0.01% |
31,701
| – | – |
|
2782
1stdibs.com
DIBS
$101M
| $54.4K | ﹤0.01% |
+12,119
| New | +$54.4K |
|
2783
KVH Industries
KVHI
$119M
| $53.9K | ﹤0.01% |
+11,600
| New | +$53.9K |
|
2784
GSI Technology
GSIT
$98M
| $52.5K | ﹤0.01% |
19,827
+5,890
| +42% | +$15.6K |
|
2785
Oramed Pharmaceuticals
ORMP
$98.8M
| $50.3K | ﹤0.01% |
19,591
| – | – |
|
2786
Esperion Therapeutics
ESPR
$573M
| $50K | ﹤0.01% |
+22,518
| New | +$50K |
|
|
TUYA
2787
Tuya Inc
TUYA
$1.57B
| $49.9K | ﹤0.01% |
29,178
| – | – |
|
|
AIFU
2788
AIFU Inc. Class A Ordinary Share
AIFU
$82.6M
| $46.7K | ﹤0.01% |
1,174
-62
| -5% | -$2.47K |
|
|
AMTD
2789
AMTD IDEA Group
AMTD
$97.9M
| $44.1K | ﹤0.01% |
26,417
| – | – |
|
2790
Altice USA
ATUS
$1.12B
| $44K | ﹤0.01% |
21,561
-563
| -3% | -$1.15K |
|
|
MAGN
2791
Magnera Corporation
MAGN
$393M
| $42.9K | ﹤0.01% |
2,375
+259
| +12% | +$4.68K |
|
|
AEVA
2792
Aeva Technologies
AEVA
$903M
| $38.5K | ﹤0.01% |
+15,264
| New | +$38.5K |
|
|
ACCD
2793
DELISTED
Accolade, Inc. Common Stock
ACCD
| $37.4K | ﹤0.01% |
10,451
-1,471
| -12% | -$5.27K |
|
|
OMGA
2794
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $37.4K | ﹤0.01% |
18,048
-7,267
| -29% | -$15K |
|
2795
Amylyx Pharmaceuticals
AMLX
$1.24B
| $36.2K | ﹤0.01% |
19,041
-359,757
| -95% | -$684K |
|
2796
Crexendo
CXDO
$204M
| $36K | ﹤0.01% |
11,458
+500
| +5% | +$1.57K |
|
2797
China Automotive Systems, Inc. Ordinary Share
CAAS
$138M
| $35.7K | ﹤0.01% |
+10,059
| New | +$35.7K |
|
2798
Corvus Pharmaceuticals
CRVS
$434M
| $33.2K | ﹤0.01% |
18,248
| – | – |
|
2799
Forge Global Holdings
FRGE
$239M
| $28.3K | ﹤0.01% |
1,292
-4,892
| -79% | -$107K |
|
|
NIU
2800
Niu Technologies
NIU
$316M
| $27.8K | ﹤0.01% |
15,966
+740
| +5% | +$1.29K |
|